Sec. 491.051. PATIENT ELIGIBILITY. A patient is eligible to access and use an investigational sun protection product if the patient's physician: (1) in consultation with the patient, has considered all other sun protection products currently approved by the United States Food and Drug Administration and determined those products are less effective in comparison to an investigational sun protection product; and (2) recommends or prescribes in writing an investigational sun protection product for the patient. Added by Acts 2025, 89th Leg., R.S., Ch. 352 (S.B. 670), Sec. 2, eff. June 20, 2025.
Patient Eligibility
Tex. Health and Safety Code § 491.051 (as added by Acts 2025, 89th Leg., R.S., Ch. 352 (S.B. 670)), under Patient Access To Investigational Sun Protection Products.
Tex. Health and Safety Code § 491.051 (as added by Acts 2025, 89th Leg., R.S., Ch. 352 (S.B. 670))